Skinvisible (SKVI) Payables (2010 - 2026)

Skinvisible (SKVI) has 17 years of Payables data on file, last reported at $1.4 million in Q1 2026.

• For the quarter ending Q1 2026, Payables rose 3.32% year-over-year to $1.4 million; the trailing twelve-month figure through Mar 2026 stood at $1.4 million (up 3.32% YoY), and the FY2025 full-year result was $1.6 million, up 86.93% from the prior year.
• Payables eased to $1.4 million in Q1 2026, from $1.6 million in the prior quarter.
• In the past five years, Payables ranged from a high of $4.0 million in Q3 2022 to a low of $166057.0 in Q1 2023.
• A 5-year average of $1.5 million and a median of $1.3 million in 2025 frame the typical range for Payables.
• Across the five-year window, Payables plunged 95.23% in 2023 and surged 447.5% in 2024, its largest moves.
• Tracing SKVI's Payables over 5 years: stood at $1.2 million in 2022, then slumped by 61.46% to $478668.0 in 2023, then surged by 79.45% to $858993.0 in 2024, then soared by 86.93% to $1.6 million in 2025, then slipped by 15.62% to $1.4 million in 2026.
• Business Quant data shows SKVI's Payables at $1.4 million in Q1 2026, $1.6 million in Q4 2025, and $1.5 million in Q3 2025.